[February 27, 2017]

Global Hematology Partnering Analysis 2010-2017: Deal Trends, Players and Financials - Research and Markets

Research and Markets has announced the addition of the "Global Hematology Partnering 2010-2017: Deal trends, players and financials" report to their offering.

Global Hematology Partnering 2010 to 2017 provides the full collection of Hematology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Hematology disease deal trends, key players and top deal values allowing the understanding of how, hy and under what terms companies are currently entering Hematology deals.

The report presents financial deal terms values for Hematology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Report scope:

• Trends in Hematology dealmaking in the biopharma industry since 2010
• Analysis of Hematology deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Hematology deal contract documents
• Comprehensive access to over 3500 Hematology deal records
• The leading Hematology deals by value since 2010
• Most active Hematology dealmakers since 2010

In Global Hematology Partnering 2010 to 2017, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication

For more information about this report visit http://www.researchandmarkets.com/research/wzz3n7/global_hematology

View source version on businesswire.com: http://www.businesswire.com/news/home/20170227006369/en/

[ Back To TMCnet.com's Homepage ]